9.0K est. views
business1w ago

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade - Merck.com

https://www.merck.com/news/merck-to-acquire-verona-pharma-expanding-its-portfolio-to-include-ohtuvayre-ensifentrine-a-first-in-class-copd-maintenance-treatment-for-adults-and-expected-to-drive-growth-into-the-next-dec/https://www.cnbc.com/2025/07/09/merck-to-acquire-verona-pharma.htmlhttps://apnews.com/article/merck-verona-ohtuvayre-copd-adcb220a202e33de8f93441dbd0eb8df
Merck.com and 3 more
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade - Merck.com Open in Merck.com
Vote 4
0

References

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck spends $10 billion for Verona, gaining access to its COPD medication

Merck spends $10 billion for Verona, gaining access to its COPD medication

UK-based biotech firm Verona snapped up by Merck in $10bn deal

UK-based biotech firm Verona snapped up by Merck in $10bn deal

Related Topics

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Top 560 Internet News Today

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement